PL80742B1 - Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] - Google Patents
Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] Download PDFInfo
- Publication number
- PL80742B1 PL80742B1 PL1969142308A PL14230869A PL80742B1 PL 80742 B1 PL80742 B1 PL 80742B1 PL 1969142308 A PL1969142308 A PL 1969142308A PL 14230869 A PL14230869 A PL 14230869A PL 80742 B1 PL80742 B1 PL 80742B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- compound
- dibenzo
- pharmaceutically acceptable
- acid addition
- Prior art date
Links
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical class C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 title 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- 150000007524 organic acids Chemical class 0.000 claims abstract description 3
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 3
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 3
- BISQTCXKVNCDDA-UHFFFAOYSA-N thiepine Chemical compound S1C=CC=CC=C1 BISQTCXKVNCDDA-UHFFFAOYSA-N 0.000 claims description 9
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000000460 chlorine Chemical group 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 150000002920 oxepines Chemical class 0.000 claims description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 235000005985 organic acids Nutrition 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 239000011593 sulfur Chemical group 0.000 claims description 2
- 239000002253 acid Substances 0.000 abstract description 4
- 125000000217 alkyl group Chemical group 0.000 abstract description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 abstract description 3
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 abstract description 2
- 230000001387 anti-histamine Effects 0.000 abstract description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract description 2
- 239000007858 starting material Substances 0.000 abstract description 2
- 101100037762 Caenorhabditis elegans rnh-2 gene Proteins 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- APMCUORPNXHBQK-UHFFFAOYSA-N benzo[c][1]benzoxepine Chemical class O1C=C2C=CC=CC2=CC2=CC=CC=C12 APMCUORPNXHBQK-UHFFFAOYSA-N 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 239000003874 central nervous system depressant Substances 0.000 abstract 1
- 150000008510 dibenzothiepins Chemical class 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 abstract 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 abstract 1
- 230000003301 hydrolyzing effect Effects 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 238000001953 recrystallisation Methods 0.000 description 16
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000000543 intermediate Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 8
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- UZVGSSNIUNSOFA-UHFFFAOYSA-N dibenzofuran-1-carboxylic acid Chemical compound O1C2=CC=CC=C2C2=C1C=CC=C2C(=O)O UZVGSSNIUNSOFA-UHFFFAOYSA-N 0.000 description 6
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 6
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 239000012044 organic layer Substances 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 4
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 4
- KMAWVRYYKYVCNR-UHFFFAOYSA-N benzo[b][1]benzothiepine Chemical compound C1=CC2=CC=CC=C2SC2=CC=CC=C21 KMAWVRYYKYVCNR-UHFFFAOYSA-N 0.000 description 4
- QQQCGYCZORNOOS-UHFFFAOYSA-N benzo[b][1]benzoxepine Chemical compound C1=CC2=CC=CC=C2OC2=CC=CC=C21 QQQCGYCZORNOOS-UHFFFAOYSA-N 0.000 description 4
- 235000019400 benzoyl peroxide Nutrition 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- 230000008018 melting Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 3
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 3
- 229960002317 succinimide Drugs 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- ATYBXHSAIOKLMG-UHFFFAOYSA-N oxepin Chemical compound O1C=CC=CC=C1 ATYBXHSAIOKLMG-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- PHMYQQLTSILYGO-UHFFFAOYSA-N thiepin-2-ol Chemical compound S1C(=CC=CC=C1)O PHMYQQLTSILYGO-UHFFFAOYSA-N 0.000 description 2
- GAIRGASUWHLTOE-UHFFFAOYSA-N 3h-oxepin-2-one Chemical compound O=C1CC=CC=CO1 GAIRGASUWHLTOE-UHFFFAOYSA-N 0.000 description 1
- YRIWIXQKFZYFIY-UHFFFAOYSA-N 5,6-dimethylbenzo[b][1]benzoxepine Chemical compound CC1=C(C2=C(OC3=C1C=CC=C3)C=CC=C2)C YRIWIXQKFZYFIY-UHFFFAOYSA-N 0.000 description 1
- JRLTTZUODKEYDH-UHFFFAOYSA-N 8-methylquinoline Chemical group C1=CN=C2C(C)=CC=CC2=C1 JRLTTZUODKEYDH-UHFFFAOYSA-N 0.000 description 1
- YYCRQBVQIQOKOO-UHFFFAOYSA-N COC(C=C1)=CC2=C1OC(C=CC=C1)=C1C(CBr)=C2CBr Chemical compound COC(C=C1)=CC2=C1OC(C=CC=C1)=C1C(CBr)=C2CBr YYCRQBVQIQOKOO-UHFFFAOYSA-N 0.000 description 1
- 244000201986 Cassia tora Species 0.000 description 1
- 238000003747 Grignard reaction Methods 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000031709 bromination Effects 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- -1 dimethyl compound Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/14—[b,f]-condensed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01B—MEASURING LENGTH, THICKNESS OR SIMILAR LINEAR DIMENSIONS; MEASURING ANGLES; MEASURING AREAS; MEASURING IRREGULARITIES OF SURFACES OR CONTOURS
- G01B3/00—Measuring instruments characterised by the use of mechanical techniques
- G01B3/02—Rulers with scales or marks for direct reading
- G01B3/04—Rulers with scales or marks for direct reading rigid
- G01B3/06—Rulers with scales or marks for direct reading rigid folding
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- General Physics & Mathematics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH1764468A CH501007A (de) | 1968-11-27 | 1968-11-27 | Verfahren zur Herstellung von neuen Thiepin- und Oxepinderivaten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL80742B1 true PL80742B1 (en) | 1975-08-30 |
Family
ID=4426992
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1969142308A PL80742B1 (en) | 1968-11-27 | 1969-11-26 | Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] |
| PL1969137136A PL80395B1 (en) | 1968-11-27 | 1969-11-26 | Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1969137136A PL80395B1 (en) | 1968-11-27 | 1969-11-26 | Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3636045A (en, 2012) |
| AT (2) | AT294104B (en, 2012) |
| BE (1) | BE742299A (en, 2012) |
| BR (1) | BR6914562D0 (en, 2012) |
| CH (2) | CH501007A (en, 2012) |
| CS (2) | CS166246B2 (en, 2012) |
| DE (2) | DE1965969C3 (en, 2012) |
| DK (1) | DK130214B (en, 2012) |
| FI (1) | FI50628C (en, 2012) |
| FR (1) | FR2024380B1 (en, 2012) |
| GB (2) | GB1297386A (en, 2012) |
| HK (1) | HK22376A (en, 2012) |
| IE (1) | IE33862B1 (en, 2012) |
| IL (2) | IL33435A (en, 2012) |
| KE (1) | KE2608A (en, 2012) |
| MY (1) | MY7600094A (en, 2012) |
| NL (1) | NL164284C (en, 2012) |
| NO (1) | NO127401B (en, 2012) |
| PL (2) | PL80742B1 (en, 2012) |
| SE (2) | SE374371B (en, 2012) |
| YU (2) | YU33872B (en, 2012) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH532038A (de) * | 1970-05-25 | 1972-12-31 | Ciba Geigy Ag | Verfahren zur Herstellung von neuen Cycloheptenderivaten |
| US4112110A (en) * | 1974-02-22 | 1978-09-05 | Ciba-Geigy Corporation | Oxygenated azatetracyclic compounds |
| SE7504508L (sv) * | 1974-05-10 | 1975-11-11 | Ciba Geigy Ag | Nya heterocykliska s-imino-s-oxider. |
| NL7414038A (nl) * | 1974-10-28 | 1976-05-03 | Akzo Nv | Nieuwe tetracyclische pyrrolidino derivaten. |
| US4154836A (en) * | 1976-05-24 | 1979-05-15 | Akzona Incorporated | Tension reducing 1,2,3,4,4a,13b-hexahydro-dibenz[2,3;6,7]oxepino[4,5-c]pyridines |
| US4271179A (en) * | 1976-05-24 | 1981-06-02 | Akzona Incorporated | 1,2,3,3a,8,12b-Hexahydro-dibenzo[1,2;5,6]cyclohepta[3,4-C]pyrroles and pharmaceutical use thereof |
| NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
| US4271177A (en) * | 1976-05-24 | 1981-06-02 | Akzona Incorporated | 2,3,3a,12b-Tetrahydro-1H-dibenzo[2,3;6,7]thiepino[4,5-c]pyrroles and pharmaceutical use thereof |
| US4177275A (en) * | 1976-05-24 | 1979-12-04 | Akzona Inc. | Tension reducing 2,3,4,4a,9,13b-hexahydro-1H-dibenzo[b,f]pyrido[3,4-d]azepine derivatives |
| EP0007450A1 (de) * | 1978-07-07 | 1980-02-06 | Ciba-Geigy Ag | Azatetracyclische Carbonitrile, ihre Herstellung, pharmazeutische Präparate, die diese enthalten und deren Verwendung |
| EP0030916B1 (de) * | 1979-12-10 | 1984-08-29 | Ciba-Geigy Ag | Azatetracyclische Carbonitrile |
| DE202009001592U1 (de) | 2009-02-09 | 2009-08-27 | Fidan, Cetin | Zollstock mit integrierter Beleuchtung |
| CN117304166A (zh) * | 2023-09-20 | 2023-12-29 | 贵州农业职业学院 | 一种新的扎托布洛芬衍生物及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH440318A (de) * | 1964-11-03 | 1967-07-31 | Geigy Ag J R | Verfahren zur Herstellung von neuen Thiepin- und Oxepinderivaten |
-
1968
- 1968-11-27 CH CH1764468A patent/CH501007A/de not_active IP Right Cessation
- 1968-11-27 CH CH1048570A patent/CH507232A/de not_active IP Right Cessation
-
1969
- 1969-11-19 US US878175A patent/US3636045A/en not_active Expired - Lifetime
- 1969-11-20 NL NL6917506.A patent/NL164284C/xx not_active IP Right Cessation
- 1969-11-20 SE SE7007890A patent/SE374371B/xx unknown
- 1969-11-20 FI FI693352A patent/FI50628C/fi active
- 1969-11-20 SE SE15969/69A patent/SE343577B/xx unknown
- 1969-11-20 DK DK614969AA patent/DK130214B/da unknown
- 1969-11-20 NO NO04601/69A patent/NO127401B/no unknown
- 1969-11-24 CS CS7724A patent/CS166246B2/cs unknown
- 1969-11-24 CS CS6275A patent/CS166247B2/cs unknown
- 1969-11-26 GB GB5784969A patent/GB1297386A/en not_active Expired
- 1969-11-26 IL IL33435A patent/IL33435A/xx unknown
- 1969-11-26 AT AT1104769A patent/AT294104B/de not_active IP Right Cessation
- 1969-11-26 PL PL1969142308A patent/PL80742B1/pl unknown
- 1969-11-26 AT AT643570A patent/AT293402B/de not_active IP Right Cessation
- 1969-11-26 PL PL1969137136A patent/PL80395B1/pl unknown
- 1969-11-26 IE IE1598/69A patent/IE33862B1/xx unknown
- 1969-11-26 BR BR214562/69A patent/BR6914562D0/pt unknown
- 1969-11-26 GB GB2484172A patent/GB1297387A/en not_active Expired
- 1969-11-26 DE DE1965969A patent/DE1965969C3/de not_active Expired
- 1969-11-26 DE DE1959405A patent/DE1959405C3/de not_active Expired
- 1969-11-26 YU YU2963/69A patent/YU33872B/xx unknown
- 1969-11-26 IL IL40861A patent/IL40861A/en unknown
- 1969-11-27 BE BE742299A patent/BE742299A/xx unknown
- 1969-11-27 FR FR696940933A patent/FR2024380B1/fr not_active Expired
-
1970
- 1970-08-04 YU YU1980/70A patent/YU34042B/xx unknown
-
1976
- 1976-03-12 KE KE2608*UA patent/KE2608A/xx unknown
- 1976-04-14 HK HK223/76*UA patent/HK22376A/xx unknown
- 1976-12-30 MY MY94/76A patent/MY7600094A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL80742B1 (en) | Thiepino and oxepino(4 5-c)pyrrol derivatives[us3636045a] | |
| US3758528A (en) | Tricyclic compounds | |
| US3853915A (en) | 9-or 10-halo-4h-benzo{8 4,5{9 cyclo-hepta{8 1,2-b{9 thiophen-4-ones | |
| US4882351A (en) | Tricyclic compounds | |
| EP0011067B1 (en) | Prostaglandin antagonists, their production and their pharmaceutical compositions | |
| US3862156A (en) | 4h-benzo{8 4,5{9 cyclohepta{8 1,2-6{9 thiophenes | |
| US3309404A (en) | Derivatives of dibenzocycloheptenes and a process for their preparation | |
| JPS6021994B2 (ja) | 置換されたチエノベンゼンジアゼピノン、その酸付加塩、その製法及びこれを含有する胃腸薬 | |
| JP2003522180A (ja) | 新規な正のアロステリックａｍｐａ受容体モジュレーター（ｐａａｒｍ）、その製法及び医薬組成物としての使用 | |
| PL70352B2 (pl) | Sposób wytwarzania nowych pochodnych azepiny | |
| CA2047236C (en) | Substituted 3-amino chromans | |
| US2894947A (en) | Phenthiazine derivatives | |
| JPH0256478A (ja) | ２，３，４，５―テトラヒドロ―１―ベンズオキセピン―３，５―ジオン誘導体及びその製法 | |
| PL95266B1 (pl) | Sposob wytwarzania nowych pochodnych tiaksantenu | |
| US4996211A (en) | Substituted dibenzocycloheptenimines | |
| US4052412A (en) | Benzo cycloheptathiophene carboxylic acid derivatives | |
| US4137323A (en) | Organic compounds | |
| US3502717A (en) | 2-arylthio and 2-arylsulfonyl benzoic acid | |
| EP0138533B1 (en) | 6h-dibenz(b,f)thiepin compounds | |
| IL32311A (en) | Benzofuran and thianaphthene carboxylic acids,their preparation and pharmaceutical compositions containing them | |
| US3130192A (en) | Azepines and n-amevoalkyl | |
| DE1235327B (de) | Verfahren zur Herstellung von in 11-Stellung basisch substituierten Dibenzo [b, f] thiepin- bzw. -oxepin-10(11H)-onen | |
| US3682959A (en) | BENZOTHIEPINO{8 4,5-c{9 {0 PYRROLES | |
| JPS62149672A (ja) | ４Ｈ−ベンゾ〔４，５〕シクロヘプタ〔１，２−ｂ〕チオフエン誘導体 | |
| PL81553B1 (en, 2012) |